Heligenics, Inc.
Biotechnology company · Las Vegas, Nevada, United States
Heligenics, Inc. is a biotechnology company headquartered in Las Vegas, Nevada, United States. Its earliest recorded incorporation is in 2019. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.2 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $2.6 million sold in a notice filed in 2025.
Heligenics at a glance
What does Heligenics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $1.2 million in total (2023 to 2025). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $2.6 million sold (2025).
Frequently asked questions about Heligenics
Where is Heligenics headquartered?
Heligenics, Inc. is headquartered in Las Vegas, Nevada, United States.
What does Heligenics do?
Heligenics, Inc. is a biotechnology company.
When was Heligenics founded?
The earliest incorporation on record for Heligenics, Inc. is in 2019, according to public company registers.
Similar companies
- PharmaCyte Biotech, Inc.Las Vegas, Nevada, United States
- Research & Diagnostic AntibodiesLas Vegas, Nevada, United States
- Frontier Health LLCLas Vegas, Nevada, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences